|
W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
| Catalog Number |
CXT261412 |
| Medical Device Problem Code |
Fracture (1260)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/25/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
H6: code c19-a review of the manufacturing records indicated the lot met pre-release manufacturing specifications.H6: code b18-the device was discarded and, therefore, was not available for engineering analysis by gore.H6: code d15-there is insufficient information available for gore to reasonably draw conclusions related to aspects of the event, therefore conclusion code ¿d15: cause not established¿ is being used.Insufficient information may include limited or missing relevant medical records, involvement of multiple implanted devices (including non-gore devices) in the field of treatment, patient non-compliance, and/or a general lack of available detail or specificity related to an adverse event and/or device.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2026, the patient underwent an endovascular procedure to treat a ruptured aneurysm, utilizing gore® excluder® conformable aaa endoprosthesis (cxt261412).It was reported during the procedure, after the stent graft was deployed, upon removing the delivery catheter of cxt261412, the nose cone broke off from the delivery catheter.Physician was able to easily remove the sheath and delivery catheter, and no apparent damage was noted on the sheath.A new sheath was inserted, and physician ballooned the broken nose cone into the sheath, and successfully removed both the sheath and the nose cone.The cause of this breakage is unknown, as no resistance was noted upon removal.No patient adverse events occurred due to this.The patient tolerated the procedure.
|
| |
|
Search Alerts/Recalls
|
|
|